Read More Pharma Industry News COURSE trial reveals promising results for TEZSPIRE in COPD patients with high eosinophil counts In a significant development in chronic obstructive pulmonary disease (COPD) management, the Phase IIa COURSE trial, a proof-of-concept… byPallavi MadhirajuMay 20, 2024